SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-013223
Filing Date
2021-10-15
Accepted
2021-10-15 16:15:48
Documents
35
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20210831x10q.htm   iXBRL 10-Q 604105
2 EX-31.1 tmb-20210831xex31d1.htm EX-31.1 11671
3 EX-31.2 tmb-20210831xex31d2.htm EX-31.2 11955
4 EX-32.1 tmb-20210831xex32d1.htm EX-32.1 6701
5 EX-32.2 tmb-20210831xex32d2.htm EX-32.2 7131
  Complete submission text file 0001558370-21-013223.txt   1953231

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20210831.xsd EX-101.SCH 15785
7 EX-101.CAL tmb-20210831_cal.xml EX-101.CAL 17879
8 EX-101.DEF tmb-20210831_def.xml EX-101.DEF 35240
9 EX-101.LAB tmb-20210831_lab.xml EX-101.LAB 155634
10 EX-101.PRE tmb-20210831_pre.xml EX-101.PRE 96477
11 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20210831x10q_htm.xml XML 196801
Mailing Address 9432 KATY FREEWAY HOUSTON TX 77055
Business Address 12000 RICHMOND AVE HOUSTON TX 77082 (713) 335-5697
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-Q | Act: 34 | File No.: 000-23425 | Film No.: 211326235
SIC: 2835 In Vitro & In Vivo Diagnostic Substances